• About Us
  • Brands in Conversation
    • Academic Connect
    • Marketing Trailblazers
  • Marketers in Conversation
    • Marketing Guru Speaks
  • Case Studies
  • Contact Us
    • Contribute Articles
    • Market Intelligence & Research
    • Skilling Programs
    • Internship
Search
Passionate In Marketing
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Friday, October 9, 2026
Sign in / Join
  • Home
  • Disclaimer
Facebook
Instagram
Linkedin
X
WhatsApp
Passionate In Marketing
  • About Us
  • Brands in Conversation
    • Academic Connect
    • Marketing Trailblazers
  • Marketers in Conversation
    • Marketing Guru Speaks
  • Case Studies
  • Contact Us
    • Contribute Articles
    • Market Intelligence & Research
    • Skilling Programs
    • Internship
Home Tags USFDA

Tag: USFDA

Zydus, MSN partner to Launch First Generic of Adempas® (Riociguat Tablets) in the U.S.
Brands in Conversation

Zydus, MSN partner to Launch First Generic of Adempas® (Riociguat Tablets) in the U.S.

Passionate in Marketing -
October 6, 2026
0
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Prucalopride Tablets
Brands in Conversation

Alembic Pharmaceuticals Limited receives USFDA Final Approval for Prucalopride Tablets

Author -
July 29, 2026
0
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Levothyroxine Sodium Tablets
Brands in Conversation

Alembic Pharmaceuticals Limited announces USFDA Final Approval for Levothyroxine Sodium Tablets

Author -
May 22, 2026
0
Zydus receives USFDA Orphan Drug Designation (ODD) for Desidustat for the treatment of beta-thalassemia
Brands in Conversation

Zydus receives USFDA Orphan Drug Designation (ODD) for Desidustat for the treatment of beta-thalassemia

Author -
November 7, 2025
0
Alembic Pharmaceuticals announces USFDA Final Approval for Bromfenac Ophthalmic Solution, 0.07%
Brands in Conversation

Alembic Pharmaceuticals announces USFDA Final Approval for Bromfenac Ophthalmic Solution, 0.07%

Passionate in Marketing -
July 13, 2024
0
Alembic Pharmaceuticals announces USFDA Approval for Dabigatran Etexilate Capsules, 75 mg and 150 mg and Tentative approval for Dabigatran Etexilate Capsules, 110 mg
Brands in Conversation

Alembic Pharmaceuticals announces USFDA Approval for Dabigatran Etexilate Capsules, 75 mg and 150 mg and Tentative approval for Dabigatran Etexilate Capsules, 110 mg

Passionate in Marketing -
June 19, 2024
0

EDITOR PICKS

Staze Beauty Collaborates With Actress Rhea Chakraborty to Launch ‘Caught Blushin’’, Inspired by Her Viral Blush Moment

October 8, 2026

NRAI Launches Third Chapter in Maharashtra today, Giving Western Maharashtra’s Restaurant Industry a Stronger Voice

October 8, 2026

Federal Bank Kochi Marathon Honours Asian Games Medalist Vidarsha

October 8, 2026

POPULAR POSTS

Chakli, meet Schezwan: Chheda’s and Ching’s bring the OG snack pack a first ever combo

October 7, 2026

New Logitech Ctrl Tomorrow Study Reveals Technology’s Impact On Mood, Wellbeing, Performance and Potential

October 8, 2026

From Basement Auditions to Penthouse Alliances: The First Rise Sets Off a New Power Game on Rise and Fall Season 2

October 3, 2026

POPULAR CATEGORY

  • Brands in Conversation73643
  • Academic Connect1567
  • Marketers in Conversation1113
  • Collaborations & Partnerships590
  • Marketing Guru Speaks235
  • Marketing Trailblazers32
  • Articles18
  • Case Studies17
Passionate In Marketing

ABOUT US

Passionate in Marketing is promoted by i-miRa Knowledge Solutions, a company founded in 2010 to foster various business units dedicated to creating, disseminating, and managing knowledge-based products, services, and solutions. These offerings cater to corporate entities, startups, and academic institutions alike.

Contact : [email protected]

FOLLOW US

FacebookFacebook
InstagramInstagram
LinkedinLinkedin
XX
WhatsAppWhatsApp

© 2026 | Passionate In Marketing |All Rights Reserved | Privacy Policy

  • Home
  • Disclaimer